We have located links that may give you full text access.
Investigation of the antiviral effects of Saussurea lappa root extract against SARS-CoV-2 virus.
Molecular Nutrition & Food Research 2023 May 12
SCOPE: The purpose of this study was to look into the antiviral activity of a plant extract derived from the roots of the Saussurea lappa as a food supplement against SARS-CoV-2 infection.
METHODS AND RESULTS: Vero E6 cells were used to test the neutralizing effect of Saussurea lappa extract against the SARS-CoV-2 virus. In our work, we used a real-time cell analyzer that's much more sensitive than the standard endpoint tests for anti-viral effectiveness determination, and a methodology with a very high rate of repetitive results that enables us to see the whole process. This technique allows the accurate monitoring of cell movement and changes in its ability to attach to the surface. The RTCA system is not only a well-known modern technique, but also a unique, noninvasive, and effective instrument for recording the dynamic biological condition of cells. A challenge experiment in mice was planned as a result of the in vitro analysis. A challenge test against SARS-CoV-2 was performed with 10 adult female K18-hACE2 transgenic mice in each group for this purpose. The challenge experiment on mice was based on how the Saussurea lappa extract was used in humans. The mice in Group 1 were gavaged two days before the virus was administered intranasally (in). The control group received PBS instead of the extract (Group 2). 105 TCID50 SARS-CoV-2 virus (Wuhan) was administered intranasally under anesthesia for the first three days of the experiment in the BSL-3 laboratory, and S. lappa extract was administered by gavage in the afternoon. Mice given the S. lappa extract and SARS-CoV-2 virus together survived the study on the 10th day, whereas mice in the control group given the virus and PBS became ill and/or died. In this study, the extract protected the mice against the SARS-CoV-2 virus in 90% of the cases.
CONCLUSIONS: Previous research has shown that the Saussurea plant has anti-inflammatory, antimicrobial, and analgesic properties (22, 33, 44). This study demonstrated its antiviral effect against SARS-CoV-2 in vitro and in vivo models. This article is protected by copyright. All rights reserved.
METHODS AND RESULTS: Vero E6 cells were used to test the neutralizing effect of Saussurea lappa extract against the SARS-CoV-2 virus. In our work, we used a real-time cell analyzer that's much more sensitive than the standard endpoint tests for anti-viral effectiveness determination, and a methodology with a very high rate of repetitive results that enables us to see the whole process. This technique allows the accurate monitoring of cell movement and changes in its ability to attach to the surface. The RTCA system is not only a well-known modern technique, but also a unique, noninvasive, and effective instrument for recording the dynamic biological condition of cells. A challenge experiment in mice was planned as a result of the in vitro analysis. A challenge test against SARS-CoV-2 was performed with 10 adult female K18-hACE2 transgenic mice in each group for this purpose. The challenge experiment on mice was based on how the Saussurea lappa extract was used in humans. The mice in Group 1 were gavaged two days before the virus was administered intranasally (in). The control group received PBS instead of the extract (Group 2). 105 TCID50 SARS-CoV-2 virus (Wuhan) was administered intranasally under anesthesia for the first three days of the experiment in the BSL-3 laboratory, and S. lappa extract was administered by gavage in the afternoon. Mice given the S. lappa extract and SARS-CoV-2 virus together survived the study on the 10th day, whereas mice in the control group given the virus and PBS became ill and/or died. In this study, the extract protected the mice against the SARS-CoV-2 virus in 90% of the cases.
CONCLUSIONS: Previous research has shown that the Saussurea plant has anti-inflammatory, antimicrobial, and analgesic properties (22, 33, 44). This study demonstrated its antiviral effect against SARS-CoV-2 in vitro and in vivo models. This article is protected by copyright. All rights reserved.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app